Stocks
Haemonetics Corporation (HAE) ROE US GAAP (year values) |
|||||||||
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | LTM ? | 5 years average | |||
| ROE, % | ? | 5.79% | 14.1% | 12.2% | 20.4% | 12.2% | 12.2% | ||
| Changes by years, y/y, % | -5pp | +8pp | -2pp | +8pp | -8pp | 13% | |||
Haemonetics Corporation. ROE, %
Haemonetics Corporation. ROE, changes, pp
Haemonetics Corporation (HAE) ROE US GAAP (quarter values) |
||||||||
| FY2026Q1 | FY2026Q2 | FY2026Q3 | FY2026Q4 | FY2027Q1 | LTM ? | |||
| ROE, % | ? | 18.5% | 19.8% | 19.2% | 12.2% | 11.5% | 12.2% | |
| Changes by years, y/y, % | +6pp | +6pp | +5pp | -8pp | -7pp | |||
| Changes by quarters, q/q, % | -2pp | +1pp | -1pp | -7pp | -1pp | |||
